Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 61 AL 75

Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease

Driver JA, Zhou XZ, Lu KP.

Biochim Biophys Acta. 2015 Oct;1850(10):2069-76. doi: 10.1016/j.bbagen.2014.12.025. Epub 2015 Jan 10.

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease

Walker D, Lue LF, Paul G, Patel A, Sabbagh MN.

Expert Opin Investig Drugs. 2015 Mar;24(3):393-9. doi: 10.1517/13543784.2015.1001490. Epub 2015 Jan 14.

Validation of AD-CSF-Index in Chinese patients with Alzheimer's disease and nondemented controls

Chu LW, Shea YF, Ha J.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):522-6. doi: 10.1177/1533317514567126. Epub 2015 Jan 14.

Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders

Lefort R.

Neurotherapeutics. 2015 Jan;12(1):19-28. doi: 10.1007/s13311-014-0328-4.

Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease

Agostinho P, Pliássova A, Oliveira CR, Cunha RA.

J Alzheimers Dis. 2015;45(2):329-47. doi: 10.3233/JAD-142730.

Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study

Miranda LF, Gomes KB, Silveira JN, Pianetti GA, Byrro RM, Peles PR, Pereira FH, Santos TR, Assini AG, Ribeiro VV, Tito PA, Matoso RO, Lima TO, Moraes EN, Caramelli P.

J Alzheimers Dis. 2015;45(2):609-20. doi: 10.3233/JAD-142148.

Deficits in Everyday Function Differ in AD and FTD

Park LQ, Harvey D, Johnson J, Farias ST.

Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):301-6. doi: 10.1097/WAD.0000000000000081.

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”; Hippocampus Study Group.

Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003. Epub 2015 Jan 14.

Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD

Thal DR, Fändrich M.

Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2.

Potential of neural stem cell-based therapies for Alzheimer's disease

Li XY, Bao XJ, Wang RZ.

J Neurosci Res. 2015 Sep;93(9):1313-24. doi: 10.1002/jnr.23555. Epub 2015 Jan 19.

Nutritional supplementation for Alzheimer's disease?

Shea TB, Remington R.

Curr Opin Psychiatry. 2015 Mar;28(2):141-7. doi: 10.1097/YCO.0000000000000138.

Accelerating Alzheimer's research through 'natural' animal models

Braidy N, Poljak A, Jayasena T, Mansour H, Inestrosa NC, Sachdev PS.

Curr Opin Psychiatry. 2015 Mar;28(2):155-64. doi: 10.1097/YCO.0000000000000137.

Stuck in the mire

Shelanski M, Lefort R.

Neurotherapeutics. 2015 Jan;12(1):1-2. doi: 10.1007/s13311-014-0333-7.

A systems approach to drug discovery in Alzheimer's disease

Shelanski M, Shin W, Aubry S, Sims P, Alvarez MJ, Califano A.

Neurotherapeutics. 2015 Jan;12(1):126-31. doi: 10.1007/s13311-014-0335-5.

The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans

May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ.

J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias